Literature DB >> 19868030

IMMUNITY FACTORS IN PNEUMOCOCCUS INFECTION IN THE DOG.

C G Bull1.   

Abstract

Intravenous inoculations of from 1 to 3 cc. per kilo of body weight of a bouillon culture of virulent pneumococci produce septicemia and meningitis in dogs. The injected pneumococci leave the circulation rapidly, but begin to reinvade the blood from 24 to 48 hours later. The septicemia reaches its climax between the 4th and 5th days and then abruptly declines, the blood becoming sterile within from 1 to 3 days after the height of the septicemia is reached. The initial disappearance of the pneumococci from the circulation has been found to be due to agglutination of the diplococci in the blood stream and accumulation of the clumps in the lungs, liver, spleen, etc. If the dogs are reinoculated during the ascension of the septicemia, the injected diplococci leave the circulation as rapidly as in normal dogs. Cultures isolated in this stage of the infection, both before and from 3 to 4 hours after the reinoculation, are resistant to the agglutinins and opsonins of immune sera that agglutinate and opsonize the cultures with which the dogs were originally infected. Thus it follows that the pneumococci are able to reinvade the circulation because they have acquired a fastness to the existing antibodies and not because the antibodies have been bound or exhausted. By reinoculating dogs at the time of the crisis in the septicemia it has been shown that the agglutination of the pneumococci is more rapid and complete and that the diplococci leave the circulation much more rapidly than in normal dogs. Hence acquired antibodies are operative within the animals at this time although they cannot be demonstrated in vitro until from 24 to 48 hours later. Pneumococci isolated as the infection is subsiding are more susceptible to the action of immune sera than the original cultures injected. It is probable that all the dogs would have survived the infection if a meningitis had not developed. In the acutely fatal cases of meningitis few pneumococci are phagocyted, while in the milder and convalescent cases much phagocytosis occurs. It is suggested that the incubation period of infectious diseases is due to the fact that the infecting agents must become adapted to the adverse conditions encountered in the newly infected host before they can multiply sufficiently to produce the symptoms of disease. It is further suggested that epidemics may arise because the infectious agent is passed from person to person in the ascending stage of the disease and thus enters new hosts in a state of maximum resistance to the natural antibodies of such individuals. When early contacts are avoided, epidemics tend to subside because the infectious agent is weakened by the action of acquired antibodies during the period of convalescence.

Entities:  

Year:  1916        PMID: 19868030      PMCID: PMC2125412          DOI: 10.1084/jem.24.1.7

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  6 in total

1.  EXPERIMENTAL PNEUMONIA BY INTRABRONCHIAL INSUFFLATION.

Authors:  R V Lamar; S J Meltzer
Journal:  J Exp Med       Date:  1912-02-01       Impact factor: 14.307

2.  VARIATIONS IN THE PNEUMOCOCCUS INDUCED BY GROWTH IN IMMUNE SERUM.

Authors:  L M Stryker
Journal:  J Exp Med       Date:  1916-07-01       Impact factor: 14.307

3.  ANTIBLASTIC IMMUNITY.

Authors:  A R Dochez; O T Avery
Journal:  J Exp Med       Date:  1916-01-01       Impact factor: 14.307

4.  THE MECHANISM OF THE CURATIVE ACTION OF ANTIPNEUMOCOCCUS SERUM.

Authors:  C G Bull
Journal:  J Exp Med       Date:  1915-10-01       Impact factor: 14.307

5.  PNEUMONIC LESIONS MADE BY INTRABRONCHIAL INSUFFLATION OF NON-VIRULENT PNEUMOCOCCI.

Authors:  M Wollstein; S J Meltzer
Journal:  J Exp Med       Date:  1913-03-01       Impact factor: 14.307

6.  A METHOD OF SERUM TREATMENT OF PNEUMOCOCCIC SEPTICEMIA IN RABBITS.

Authors:  C G Bull
Journal:  J Exp Med       Date:  1915-10-01       Impact factor: 14.307

  6 in total
  13 in total

Review 1.  The role of complement in host resistance to bacteria.

Authors:  E J Brown; K A Joiner; M M Frank
Journal:  Springer Semin Immunopathol       Date:  1983

2.  THE OCCURRENCE OF DEGRADED PNEUMOCOCCI IN VIVO.

Authors:  H A Reimann
Journal:  J Exp Med       Date:  1927-04-30       Impact factor: 14.307

3.  The splanchnic removal in rabbits during fatal bacteremias of the circulating organisms and of superimposed non-pathogenic bacteria.

Authors:  S P MARTIN; G P KERBY
Journal:  J Exp Med       Date:  1950-07-01       Impact factor: 14.307

4.  A consideration of the pathogenesis of bacterial meningitis: review of experimental and clinical studies.

Authors:  D H HARTER; R G PETERSDORF
Journal:  Yale J Biol Med       Date:  1960-02

5.  STUDIES ON PNEUMOCOCCUS GROWTH INHIBITION : VII. THE RELATION OF OPSONINS TO NATURAL RESISTANCE AGAINST PNEUMOCOCCUS INFECTION.

Authors:  O H Robertson; R H Sia
Journal:  J Exp Med       Date:  1927-07-31       Impact factor: 14.307

6.  THE EFFECT OF INJECTIONS OF HEMOLYTIC STREPTOCOCCI ON SUSCEPTIBLE AND INSUSCEPTIBLE ANIMALS.

Authors:  J G Hopkins; J T Parker
Journal:  J Exp Med       Date:  1918-01-01       Impact factor: 14.307

7.  A STUDY OF THE MECHANISM OF RECOVERY FROM EXPERIMENTAL PNEUMOCOCCUS INFECTION.

Authors:  O H Robertson; S T Woo; S N Cheer; L P King
Journal:  J Exp Med       Date:  1928-01-31       Impact factor: 14.307

8.  THE PRODUCTION OF ANTIPNEUMOCOCCIC SERUM.

Authors:  R Cole; H F Moore
Journal:  J Exp Med       Date:  1917-10-01       Impact factor: 14.307

9.  CHANGES IN HUMORAL IMMUNITY OCCURRING DURING THE EARLY STAGES OF EXPERIMENTAL PNEUMOCOCCUS INFECTION.

Authors:  E E Terrell
Journal:  J Exp Med       Date:  1930-02-28       Impact factor: 14.307

10.  THE PATHOLOGIC EFFECTS OF STREPTOCOCCI FROM CASES OF POLIOMYELITIS AND OTHER SOURCES.

Authors:  C G Bull
Journal:  J Exp Med       Date:  1917-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.